Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mitochondrial stress in advanced fibrosis and cirrhosis associated with chronic hepatitis B, chronic hepatitis C, or nonalcoholic steatohepatitis.
Loureiro D, Tout I, Narguet S, Bed CM, Roinard M, Sleiman A, Boyer N, Pons-Kerjean N, Castelnau C, Giuly N, Tonui D, Soumelis V, El Benna J, Soussan P, Moreau R, Paradis V, Mansouri A, Asselah T. Loureiro D, et al. Among authors: castelnau c. Hepatology. 2023 Apr 1;77(4):1348-1365. doi: 10.1002/hep.32731. Epub 2022 Sep 16. Hepatology. 2023. PMID: 35971873 Free PMC article.
Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C.
Martinot-Peignoux M, Marcellin P, Pouteau M, Castelnau C, Boyer N, Poliquin M, Degott C, Descombes I, Le Breton V, Milotova V, et al. Martinot-Peignoux M, et al. Among authors: castelnau c. Hepatology. 1995 Oct;22(4 Pt 1):1050-6. Hepatology. 1995. PMID: 7557850 Clinical Trial.
Influence of hepatitis G virus infection on the severity of liver disease and response to interferon-alpha in patients with chronic hepatitis C.
Martinot M, Marcellin P, Boyer N, Detmer J, Pouteau M, Castelnau C, Degott C, Aupérin A, Collins M, Kolberg J, Wilber J, Benhamou JP, Erlinger S. Martinot M, et al. Among authors: castelnau c. Ann Intern Med. 1997 Jun 1;126(11):874-81. doi: 10.7326/0003-4819-126-11-199706010-00004. Ann Intern Med. 1997. PMID: 9163288
Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy.
Marcellin P, Boyer N, Gervais A, Martinot M, Pouteau M, Castelnau C, Kilani A, Areias J, Auperin A, Benhamou JP, Degott C, Erlinger S. Marcellin P, et al. Among authors: castelnau c. Ann Intern Med. 1997 Nov 15;127(10):875-81. doi: 10.7326/0003-4819-127-10-199711150-00003. Ann Intern Med. 1997. PMID: 9382365
Re-treatment with interferon alfa of patients with chronic hepatitis C.
Chow WC, Boyer N, Pouteau M, Castelnau C, Martinot-Peignoux M, Martins-Amado V, Degos F, Maghinici C, Sinegre M, Benhamou JP, Degott C, Erlinger S, Marcellin P. Chow WC, et al. Among authors: castelnau c. Hepatology. 1998 Apr;27(4):1144-8. doi: 10.1002/hep.510270432. Hepatology. 1998. PMID: 9537456
[Treatment of hepatitis B].
Marcellin P, Castelnau C, Boyer N. Marcellin P, et al. Among authors: castelnau c. Rev Med Interne. 2002 Dec;23 Suppl 5:535s-536s. doi: 10.1016/s0248-8663(02)80394-0. Rev Med Interne. 2002. PMID: 12701244 Review. French. No abstract available.
53 results